182 related articles for article (PubMed ID: 22913215)
41. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.
Straczkowski M; Dzienis-Straczkowska S; Stêpieñ A; Kowalska I; Szelachowska M; Kinalska I
J Clin Endocrinol Metab; 2002 Oct; 87(10):4602-6. PubMed ID: 12364441
[TBL] [Abstract][Full Text] [Related]
42. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
[TBL] [Abstract][Full Text] [Related]
43. Relationship of serum interleukin-6 and tumor necrosis factor alpha levels with abdominal fat distribution evaluated by ultrasonography in overweight or obese postmenopausal women.
Fenkci S; Rota S; Sabir N; Sermez Y; Guclu A; Akdag B
J Investig Med; 2006 Dec; 54(8):455-60. PubMed ID: 17169269
[TBL] [Abstract][Full Text] [Related]
44. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.
Cartier A; Lemieux I; Alméras N; Tremblay A; Bergeron J; Després JP
J Clin Endocrinol Metab; 2008 May; 93(5):1931-8. PubMed ID: 18319319
[TBL] [Abstract][Full Text] [Related]
45. Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study.
Basturk T; Unsal A; Ulas T; Koc Y; Sakaci T; Ahbap E; Borlu F
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1519-24. PubMed ID: 23111964
[TBL] [Abstract][Full Text] [Related]
46. [Tumor necrosis factor alpha (TNF-alpha) gene G-308A polymorphism relationship to insulin resistance and lipid abnormalities in children with obesity].
Pyrzak B; Wiśniewska A; Rymkiewicz-Kluczyńska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):171-4. PubMed ID: 17020650
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of selected interleukins, tumor necrosis factor, insulin and leptin in obese patients with hypertension].
Bogdański P; Kujawska-Łuczak M; Łacki J; Pupek-Musialik D
Pol Merkur Lekarski; 2003 Oct; 15(88):347-9; discussion 349-51. PubMed ID: 14974363
[TBL] [Abstract][Full Text] [Related]
48. The influence of chosen adipocytokines on blood pressure values in patients with metabolic syndrome.
Musialik K
Kardiol Pol; 2012; 70(12):1237-42. PubMed ID: 23264241
[TBL] [Abstract][Full Text] [Related]
49. [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease].
Olszanecka-Glinianowicz M; Waluszek-Kończakowska I; Zahorska-Markiewicz B; Janowska J
Endokrynol Pol; 2005; 56(2):174-8. PubMed ID: 16335686
[TBL] [Abstract][Full Text] [Related]
50. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.
Straczkowski M; Kowalska I; Stepien A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I
Diabetes Care; 2002 Oct; 25(10):1824-8. PubMed ID: 12351485
[TBL] [Abstract][Full Text] [Related]
51. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
52. Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity.
Straczkowski M; Lewczuk P; Dzienis-Straczkowska S; Kowalska I; Stepień A; Kinalska I
Metabolism; 2002 Jan; 51(1):75-8. PubMed ID: 11782876
[TBL] [Abstract][Full Text] [Related]
53. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway.
Fernandez-Real JM; Broch M; Vendrell J; Ricart W
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1552-6. PubMed ID: 12975637
[TBL] [Abstract][Full Text] [Related]
54. Serum soluble tumor necrosis factor-alpha receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity.
Rönnemaa T; Pulkki K; Kaprio J
J Clin Endocrinol Metab; 2000 Aug; 85(8):2728-32. PubMed ID: 10946872
[TBL] [Abstract][Full Text] [Related]
55. Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial.
Bogdanski P; Szulinska M; Suliburska J; Pupek-Musialik D; Jablecka A; Witmanowski H
J Endocrinol Invest; 2013 Apr; 36(4):221-6. PubMed ID: 22732180
[TBL] [Abstract][Full Text] [Related]
56. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
57. The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans.
Hivert MF; Sullivan LM; Shrader P; Fox CS; Nathan DM; D'Agostino RB; Wilson PW; Benjamin EJ; Meigs JB
Metabolism; 2010 Apr; 59(4):540-6. PubMed ID: 19846171
[TBL] [Abstract][Full Text] [Related]
58. Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation.
Suliburska J; Bogdanski P; Szulinska M; Pupek-Musialik D; Jablecka A
Eur J Nutr; 2014; 53(2):387-93. PubMed ID: 23708056
[TBL] [Abstract][Full Text] [Related]
59. Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance.
Straczkowski M; Kowalska I; Dzienis-Straczkowska S; Stepién A; Skibińska E; Szelachowska M; Kinalska I
Eur J Endocrinol; 2001 Sep; 145(3):273-80. PubMed ID: 11517007
[TBL] [Abstract][Full Text] [Related]
60. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.
Arroyo E; Wells AJ; Gordon JA; Varanoske AN; Gepner Y; Coker NA; Church DD; Fukuda DH; Stout JR; Hoffman JR
Exp Gerontol; 2017 Dec; 100():28-35. PubMed ID: 29038027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
